Bacterial Infections Viral Infections Fungal Infections Sepsis Antibiotic Treatment Post-Surgery Complications Urinary Tract Infections Antibiotic Resistance Respiratory Infections Gastrointestinal Infections Polymicrobial Infections Burkholderia cepacia Post-Operative Care Symptoms Microbial Infections Gut Infections Hospital Infections Post-Surgical Complications Septicemia Pathogens HIV and Hepatitis Exposure C. difficile Seasonal Illnesses E.coli Infection Blood Clots Antimicrobial Stewardship Parasitic Infections Foot Health Surgery Contagious Diseases Hospital Acquired Infections Pneumonia Flu Older Adults Hospitalization Piercing Airborne Infections Microbial Keratitis Necrotizing Fasciitis Human Papillomavirus (HPV) Sexually Transmitted Infections Treatment of Complications Eye Infections Pus Formation C. diff Covid-19 Parasites Osteomyelitis Influenza A Neonatal Care Healthcare-Associated Infections Septic Hip Complications Clostridium botulinum ICU Treatment Urinary Tract Infection E. coli Hospital-Acquired Infections Surgical Site Infections Adverse Health Effects Pus Discharge Gut Health Pus Urinary Infections Pediatric Care Pediatric Infections
FDA testing identified yeast, mold alongside Achromobacter contamination, raising concern for severe infections in immunocompromised users.
